Skip to main content


Fig. 2 | BMC Cancer

Fig. 2

From: Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC

Fig. 2

Intrapatient variation between duplicate FLICA and γH2AX assays in the Trans-NCC0901 cohort. a Variation in mean γH2AX foci per cell between duplicate DNA double-strand break (DSB) induction (γH2AX foci 1 Gy 0.5 h) and repair (γH2AX foci 4 Gy 24 h) assays in the same patient. b Variation between duplicate %FLICA0Gy and %FLICA8Gy readouts in the same patient in the general lymphocyte population. c Variation in CD4+ lymphocytes and d CD8+ lymphocytes analysed in a subset of patients

Back to article page